Specialty Billing
Oncology Medical Billing Services
Billing for oncology practices — where drug margins, infusion coding hierarchies, and per-cycle authorizations make billing precision a clinical-operations issue.
Oncology billing carries the highest dollar density in outpatient medicine: buy-and-bill drug claims where units, wastage, and NDC details decide five-figure reimbursements; infusion administration coding with hierarchy rules for initial, sequential, and concurrent services; and authorization requirements tracking each regimen, cycle, and dose change.
Our oncology billing runs at that stakes level: drug claims reconciled against pharmacy purchases, administration coding built from infusion records, authorizations tracked per protocol with dose-change updates, and patient financial coordination that respects what treatment costs families.
Why Oncology Billing Is Complex
Drug billing errors are the expensive ones — units off by a factor, undocumented wastage, NDC mismatches — and payers audit oncology drug claims specifically. Administration coding follows a strict hierarchy (initial versus sequential versus concurrent, time-based) built from start/stop documentation. Authorizations attach to regimens and doses: protocol changes mid-treatment require authorization updates or subsequent cycles deny, at chemotherapy prices.
Common Service Categories We Bill
- Chemotherapy and immunotherapy infusion services
- Buy-and-bill drug management
- Injection and supportive-care administration
- Treatment planning and complex E/M
- Oral oncolytic coordination with specialty pharmacy
Common Denial Causes in Oncology
- Drug unit and NDC edits on high-dollar claims
- Authorization mismatches after protocol or dose changes
- Administration hierarchy coding errors
- Site-of-care and specialty-pharmacy steering conflicts
Documentation Risks to Watch
- Infusion start/stop times incomplete for time-based administration codes
- Wastage not documented to payer-required specificity
- Regimen changes not synchronized with authorization updates
Coding Considerations
- Units are billed in the code’s defined increments, not milligrams — conversion errors are a classic five-figure mistake in both directions
- Concurrent and sequential infusion combinations must mirror the documented timeline exactly
Educational note: Coding and payer information on this page is general educational content, not definitive coding, legal, or reimbursement advice. CPT/ICD-10 rules and payer policies change frequently — verify specifics against current official sources and qualified professionals.
Typical Payer Challenges
- Per-cycle authorization with dose-level specificity
- White-bagging and site-of-care policies attacking buy-and-bill economics
Oncology Billing FAQs
How do you protect our drug margins?
Reconciliation and precision: billed units reconciled against pharmacy dispensing records claim by claim, wastage documented to payer requirements, NDCs verified, and underpayments on drug claims worked as their own queue — because a two-percent error rate on oncology drug revenue is a large number.
A payer wants our infusions moved to hospital or home infusion — can billing help?
Site-of-care policies are contract and advocacy issues as much as billing ones. We document the clinical and access case per patient where exceptions processes exist, track which payers apply steering, and give leadership the revenue-impact data for contracting conversations.
Related Specialties and Texas Locations
Information on this website is provided for general educational purposes only and does not constitute legal, medical, coding, reimbursement, payer, or compliance advice. Coding and payer requirements change frequently; verify current rules with official sources and qualified professionals before acting.
Talk to us about oncology billing
Request a free billing assessment and get a clear, no-obligation review of your claims process, denial patterns, and accounts receivable.